Electrospun cerium and gallium-containing silicate based 13-93 bioactive glass fibers for biomedical applications
Source abstract
Abstract
Abstract Fibrous scaffolds have gained increasing attention in tissue engineering applications because of their high porosity, and surface area. In the current study cerium or gallium- containing silicate based 13-93 bioactive glass fibers were prepared using electrospinning approach. Effect of cerium and gallium substitution (up to 5 w%) on the in vitro bioactivity, pre-osteoblast cell response and antibacterial activity of the prepared fibers were assessed. Results revealed that, addition of cerium or gallium has no negative effect on bioactivity and hydroxyapatite forming ability of the glass in long term. The biocompatibility tests on MC3T3-E1 cells using XTT assay revealed no cytotoxicity of the cerium- or gallium-containing bioactive glass fibers. The fibers prepared in the study showed no antibacterial response to the gram positive ( Staphylococcus aureus ) and gram negative ( Escherichia coli ) bacteria. Fibrous scaffolds manufactured in the study may be considered for the use in soft tissue engineering applications in near future.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Electrospinning for tissue engineering scaffolds10.1016/j.msec.2006.05.019 ↗
2. Electrospun nanofibrous scaffolds: production, characterization and applications for tissue engineering and drug delivery10.1166/jbn.2005.032 ↗
3. Electrospinning for tissue engineering and drug delivery10.1016/j.biomaterials.2008.01.011 ↗
4. Direct chemical bonding of bioactive glass-ceramic materials and bone10.1002/jbm.820070304 ↗
5. Chronology of bioactive glass development and clinical applications10.4236/njgc.2013.32011 ↗
6. Bioactive glass in tissue engineering10.1016/j.actbio.2011.03.016 ↗
7. Review of bioactive glass: from Hench to hybrids10.1016/j.actbio.2012.08.023 ↗
8. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering
9. Compositional dependence of bioactivity of glasses in the system Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2
10. Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments10.1098/rsif.2011.0611 ↗
11. Controlling ion release from bioactive glass foam scaffolds with antibacterial properties10.1007/s10856-006-0434-x ↗
12. Effect of ion substitution on properties of bioactive glasses: a review10.1016/j.ceramint.2015.02.140 ↗
13. Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate angiogenesis and heal full-thickness skin defects in a rodent model10.1016/j.biomaterials.2015.02.112 ↗
14. In vitro degradation and conversion of melt-derived microfibrous borate (13-93B3) bioactive glass doped with metal ions10.1111/jace.13207 ↗
15. Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia10.1172/JCI111353 ↗
16. Gallium in cancer treatment10.1016/S1040-8428(01)00225-6 ↗
17. Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts10.1111/j.1476-5381.2010.00665.x ↗
18. Effect of novel antibacterial gallium-carboxymethyl cellulose on Pseudomonas aeruginosa10.1039/C2DT32235H ↗
19. Cerium and yttrium oxide nanoparticles are neuroprotective10.1016/j.bbrc.2006.01.129 ↗
20. Effects of cerium ions on the proliferation, differentiation and mineralization function of primary mouse osteoblasts in vitro10.1016/S1002-0721(09)60067-3 ↗
21. Mesoporous bioactive scaffolds prepared with cerium-, gallium- and zinc-containing glasses10.1016/j.actbio.2012.09.024 ↗
22. Rare earth oxides as nanoadditives in 3-D nanocomposite scaffolds for bone regeneration10.1039/c0jm01072c ↗
23. Synthesis and characterization of Ce+3 and Ga+3 doped borate based bioactive glass scaffolds for bone tissue engineering applications
24. Preparation, in vitro mineralization and osteoblast cell response of 13-93 bioactive glass nanofibers for biomedical applications10.1016/j.msec.2015.04.037 ↗
25. Sol–gel synthesis of bioactive glass-ceramic 45s5 and its in vitro dissolution and mineralization behavior10.1111/jace.12190 ↗
26. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W10.1002/jbm.820240607 ↗
27. Cotton-wool-like bioactive glasses for bone regeneration10.1016/j.actbio.2014.05.020 ↗
28. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation10.1002/jbm.a.32824 ↗
29. The mechanism of biomineralization of bone like apatite on synthetic hydroxyapatite: an in vitro assessment10.1098/rsif.2004.0003 ↗
30. The charge effect of cationic surfactants on the elimination of fibre beads in the electrospinning of polystyrene10.1088/0957-4484/15/9/044 ↗
31. 45S5 Bioactive glass surface charge variations and the formation of a surface calcium phosphate layer in a solution containing fibronectin10.1002/1097-4636(20010305)54:3<454::AID-JBM200>3.0.CO;2-H ↗
32. Synthesis, characterization and cytocompatibility of spherical bioactive glass nanoparticles for potential hard tissue engineering applications10.1088/1748-6041/8/2/025011 ↗
33. The transition metal gallium disrupts Pseudomonas aeurigionosa iron metabolism and has antimicrobial and antibiofilm activity10.1172/JCI30783 ↗
34. Synthesis and characterization of cerium-doped glasses and in vitro evaluation of bioactivity10.1016/S0022-3093(02)01628-9 ↗
35. P.S. Murthy, V.P. Venugopalan, P. Sahoo, S. Dhara, A. Das, A.K. Tyagi, G. Saini, Gallium oxide nanoparticle induced inhibition of bacterial adhesion and biofilm formation, IEEE, 2011, pp. 490–493, 978-1-4673-0074-21111.10.1109/ICONSET.2011.6168010 ↗
36. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii10.1128/AAC.01519-12 ↗
37. Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections10.3389/fmicb.2015.00282 ↗
38. Repurposing of gallium-based drugs for antibacterial therapy10.1002/biof.1159 ↗
39. Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment10.1093/emph/eou003 ↗
40. Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infection10.1128/AAC.00616-13 ↗
41. The antibacterial effect of cerium oxide nanoparticles on Staphylococcus aureus bacteria
42. In-vitro characterization of antibacterial bioactive glass containing ceria10.1016/j.ceramint.2013.06.062 ↗
43. Does the antibacterial activity of silver nanoparticle depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli10.1128/AEM.02218-06 ↗
44. Cerium oxide nanoparticles promotes wound healing activity in in-vivo animal model10.1166/jbns.2012.1074 ↗